自我剽窃。
Self-plagiarism.
出版信息
Oncologist. 2011;16(10):1347-8. doi: 10.1634/theoncologist.2011-0312.
Abstract
The background and explanation for the retraction of Brian Rini's article from the March 2005 issue of are provided.
摘要
提供了 Brian Rini 的文章从 2005 年 3 月的撤回的背景和解释。
相似文献
1
Self-plagiarism.自我剽窃。
Oncologist. 2011;16(10):1347-8. doi: 10.1634/theoncologist.2011-0312.
2
Recycling is not always good: the dangers of self-plagiarism.重复利用并不总是好事：自我剽窃的危害。
ACS Nano. 2012 Jan 24;6(1):1-4. doi: 10.1021/nn3000912.
3
Issues and rules for authors concerning authorship versus acknowledgements, dual publication, self plagiarism, and salami publishing.作者在署名与致谢、重复发表、自我剽窃及切香肠式发表方面的问题与规则。
Res Nurs Health. 2008 Aug;31(4):295-7. doi: 10.1002/nur.20280.
4
Authorship, plagiarism, and copyright transfer in the scientific universe.科学领域中的作者身份、抄袭与版权转让。
Clinics (Sao Paulo). 2019;74:e1312. doi: 10.6061/clinics/2019/e1312. Epub 2019 Jul 29.
5
[Ethical conflicts in scientific publishing: self-plagiarism].[科学出版中的伦理冲突：自我剽窃]
Radiologia. 2016 Mar-Apr;58(2):79-80. doi: 10.1016/j.rx.2016.01.008.
6
Ethical dilemmas in journal publication.期刊发表中的伦理困境。
Clin Dermatol. 2012 Mar-Apr;30(2):231-6. doi: 10.1016/j.clindermatol.2011.06.013.
7
Who wrote this paper? Basics of authorship and ethical issues.这篇论文是谁写的？署名的基本情况及伦理问题。
Acad Emerg Med. 2004 Jan;11(1):76-7. doi: 10.1197/j.aem.2003.08.015.
8
Commentary: What's wrong with ghostwriting?评论：代笔写作有什么问题？
Bioethics. 2010 Jul;24(6):284-6. doi: 10.1111/j.1467-8519.2010.01828.x. Epub 2010 May 17.
9
Changing ethical standards in scientific publication.
Foot Ankle Int. 2004 Nov;25(11):769-70. doi: 10.1177/107110070402501101.
10
Self-plagiarism.自我剽窃。
Anaesthesia. 2011 Mar;66(3):220-1. doi: 10.1111/j.1365-2044.2011.06645.x.
本文引用的文献
1
The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.血管生成抑制剂在肾细胞癌治疗中的当前作用。
Semin Oncol. 2006 Oct;33(5):596-606. doi: 10.1053/j.seminoncol.2006.06.003.
2
Molecularly targeted therapy in renal cell carcinoma.肾细胞癌的分子靶向治疗
Expert Rev Anticancer Ther. 2005 Dec;5(6):1031-40. doi: 10.1586/14737140.5.6.1031.
3
Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future development.转移性肾细胞癌中针对血管内皮生长因子的治疗：生物学、临床结果及未来发展
BJU Int. 2005 Aug;96(3):286-90. doi: 10.1111/j.1464-410X.2005.05616.x.
4
VEGF-targeted therapy in metastatic renal cell carcinoma.转移性肾细胞癌的血管内皮生长因子靶向治疗
Oncologist. 2005 Mar;10(3):191-7. doi: 10.1634/theoncologist.10-3-191.
5
Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma.血管内皮生长因子靶向治疗在肾细胞癌中的生物学特性与临床进展
J Clin Oncol. 2005 Feb 10;23(5):1028-43. doi: 10.1200/JCO.2005.01.186. Epub 2004 Nov 8.
6
Stanford investigates plagiarism charge.
Science. 1984 Apr 6;224(4644):35-6. doi: 10.1126/science.6701531.
Zotero 插件